Pharmaceutical preparation containing glycopyrronium bromide and indacaterol maleate

The present invention relates to a liquid pharmaceutical formulation and a method of administering a pharmaceutical formulation by nebulizing the pharmaceutical formulation in an inhaler. A propellant-free pharmaceutical formulation comprising: (a) glycopyrronium bromide and indacaterol maleate; (b) a solvent; (c) a pharmacologically acceptable solubilizing agent; (d) a pharmaceutically acceptable preservative; and (e) a pharmaceutically acceptable stabilizer. 本发明涉及液体药物制剂和通过在吸入器中雾化药物制剂来施用药物制剂的方法。不含抛射剂的药物制剂包括：(a)格隆溴铵和马来酸茚达特罗；(b)溶剂；(c)药理学上可接受的增溶剂；(d)药学上可接受的防腐剂，(e)药学上可接受的稳定剂。